Cargando…
Vaccinology in pediatric rheumatology: Past, present and future
With the introduction of biological disease-modifying antirheumatic drugs (bDMARDs), the treatment of pediatric patients with autoimmune/inflammatory rheumatic diseases (pedAIIRD) has advanced from the “Stone Age” to modern times, resulting in much better clinical outcomes. However, everything comes...
Autores principales: | Bizjak, Masa, Heshin-Bekenstein, Merav, Jansen, Marc H. A., Ziv, Amit, Angevare, Saskya, Uziel, Yosef, Wulffraat, Nicolaas M., Toplak, Natasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872015/ https://www.ncbi.nlm.nih.gov/pubmed/36704144 http://dx.doi.org/10.3389/fped.2022.1098332 |
Ejemplares similares
-
Editorial: Vaccination in children with immune-mediated diseases
por: Toplak, Natasa, et al.
Publicado: (2023) -
Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
por: Minoia, Francesca, et al.
Publicado: (2022) -
Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study
por: Heshin-Bekenstein, Merav, et al.
Publicado: (2023) -
Intestinal malrotation as a misdiagnosis of pediatric colchicine resistant familial Mediterranean fever
por: Heshin-Bekenstein, Merav, et al.
Publicado: (2015) -
COVID-19-related anxiety trajectories in children, young people and adults with rheumatic diseases
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2023)